General MedicationsORALGeneric

CLORAZEPATE DIPOTASSIUM

Standard Dose

3.75MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview CLORAZEPATE DIPOTASSIUM is listed in Drugs@FDA under application 072219 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CLORAZEPATE DIPOTASSIUM Form and strength CAPSULE;ORAL - 3.75MG Sponsor AUROLIFE PHARMA LLC Submission history Latest submission status date: 2016-12-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLORAZEPATE DIPOTASSIUM is listed in Drugs@FDA under application 072219 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLORAZEPATE DIPOTASSIUM Form and strength CAPSULE;ORAL - 3.75MG Sponsor AUROLIFE PHARMA LLC Submission history Latest submission status date: 2016-12-16 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.